Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 6, 2000, Pages 813-818

  Russell, P ^a   Eley, S M ^a   Ellis, J ^a   Green, M ^a   Bell, D L ^a   Kenny, D J ^a   Titball, R W ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BURKHOLDERIA PSEUDOMALLEI; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORSE DISEASE; LD 50; MELIOIDOSIS; MOUSE; NONHUMAN; RECURRENT DISEASE; SYRIAN HAMSTER;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BURKHOLDERIA INFECTIONS; BURKHOLDERIA PSEUDOMALLEI; CIPROFLOXACIN; CRICETINAE; DOXYCYCLINE; FEMALE; GLANDERS; MELIOIDOSIS; MICE; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034090030     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.6.813     Document Type: Article

References (26)

1. Dance, D. A. (1991). Melioidosis: the tip of the iceberg? Clinical Microbiological Reviews 4, 52-60.
2. Sanford, J. P. (1995). Pseudomonas species (including melioidosis and glanders). In Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2003-9. Churchill-Livingstone, New York.
3. Leelarasamee, A., Aswapokee, N., Kobwanthanakun, S. & Aswapokee, P. (1988). In vitro susceptibility of Pseudomonas pseudomallei to new quinolones, compared with newer β-lactam antibiotics. Reviews of Infectious Diseases 10, Suppl. 1, S43.
4. Winton, M. D., Everett, E. D. & Dolan, S. A. (1988). Activities of five new fluoroquinolones against Pseudomonas pseudomallei. Antimicrobial Agents and Chemotherapy 32, 928-9.
5. Leelarasamee, A. & Bovornkitti, S. (1989). Melioidosis: Review and update. Reviews of Infectious Diseases 11, 413-25.
6. White, N. J., Dance, D. A., Chaowagul, W., Wattanagoon, Y., Wuthiekanun, V. & Pitakwatchara, N. (1989). Halving of mortality of severe melioidosis by ceftazidime. Lancet ii, 697-701.
7. Lumbiganon, P. & Sookpranee, T. (1992). Ciprofloxacin therapy for localized melioidosis. Pediatric Infectious Diseases 11, 418-19.
8. Chaowagul, W., Suputtamongkul, Y., Smith, M. D. & White, N. J. (1997). Oral fluoroquinolones for maintenance treatment of melioidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 599-601.
9. Koga, H. (1987). High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 31, 1904-8.
10. Chateau, M. T. & Caravano, R. (1993). Rapid fluorometric measurement of the intra-cellular concentration of ciprofloxacin in mouse peritoneal macrophages. Journal of Antimicrobial Chemotherapy 31, 281-7.
11. LeBel, M. (1988). Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 8, 3-33.
12. Ipatenko, N. G. (1972). Study of the bacteriostatic and bactericidal properties of certain antibiotics. Trudy Moskovskoi Veterinarnoi Akademii 61, 142-8.
13. Al-Izzi, S. A. & Al-Bassam, L. S. (1989). In vitro susceptibility of Pseudomonas mallei to antimicrobial agents. Comparative Immunology, Microbiology and Infectious Diseases 12, 5-8.
14. Antonov, Iu. V., Iliukhin, V. I., Popovtseva, L. D. & Batmanov, V. P. (1991). Sensitivity of Pseudomonas to currently used antibacterial drugs. Antibiotiki I Khimioterapiia 36, 14-16.
15. Batmanov, V. P. (1991). Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders. Antibiotiki I Khimioterapiia 36, 31-4.
16. Batmanov, V. P. (1993). Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim. Antibiotiki I Khimioterapiia 38, 18-22.
17. Batmanov, V. P. (1994). Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders. Antibiotiki I Kimioterapiya 39, 33-7.
18. Manzeniuk, I. N., Dorokhin, V. V. & Svetoch, E. A. (1994). The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments. Antibiotiki I Khimioterapiia 39, 26-30.
19. Kenny, D. J., Russell, P., Rogers, D., Eley, S. M. and Titball, R. W. (1999). In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrobial Agents and Chemotherapy 43, 2773-5.
20. Pruksachartvuthi, S., Aswapokee, N. & Thankerngpol, K. (1990). Survival of Pseudomonas pseudomallei in human phagocytes. Journal of Medical Microbiology 31, 109-14.
21. Finch, R. G. (1997). Tetracyclines. In Antibiotics and Chemotherapy: Anti-infective Agents and Their Use in Therapy, 7th edn, (O'Grady, F., Finch, R. G., Lambert, H. P. & Greenwood, D., Eds), pp. 469-84. Churchill-Livingstone, Edinburgh.
22. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
23. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27, 493-7.
24. Gaiger, S. H. (1913). Glanders in man. Journal of Comparative Pathology and Therapeutics 26, 223-36.
25. Gaiger, S. H. (1916). Glanders in man: A second attack after apparent recovery. Journal of Comparative Pathology and Therapeutics 29, 26-46.
26. Kanai, K., Kondo, E. & Kurata, T. (1996). Affinity and response of Burkholderia pseudomallei and Burkholderia cepacia to insulin. Southeast Asian Journal of Tropical Medicine and Public Health 27, 584-91.